Sarissa Capital Reminds Amarin Shareholders Today Is the Last Day to Vote “FOR” Change

Rhea-AI Summary

Sarissa Capital Management LP urges Amarin Corporation plc (NASDAQ: AMRN) shareholders to vote in favor of board changes at the company. The call to action is aimed at removing Chairman Per Wold-Olsen, whom Sarissa accuses of causing significant value destruction due to operational failures. Sarissa, as the largest shareholder, emphasizes its commitment to creating value and has proposed qualified nominees for the board. Shareholders must submit their votes by midnight (New York Time) today to ensure they count for the upcoming meeting on February 28, 2023. More information can be found on Sarissa's proxy website.

Positive

• Sarissa Capital is the largest shareholder, indicating strong alignment with shareholder interests.
• The proposed nominees include individuals with experience in turning around The Medicines Company, suggesting potential for strategic improvement.

Negative

• Current leadership under Chairman Per Wold-Olsen has been criticized for operational blunders and poor capital allocation.
• Sarissa claims significant capital waste by current leadership in efforts to exclude shareholder representatives from the board.

Sarissa Capital’s board candidates will represent shareholders and help create value at Amarin during this critical period

Sarissa Capital believes removing Chairman Per Wold-Olsen from the Amarin board is in shareholders’ best interest

GREENWICH, Conn.--(BUSINESS WIRE)-- Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):

Sarissa urges Amarin shareholders to vote “FOR” change TODAY to remake the Amarin board for shareholders at our upcoming meeting. Given the voting logistics for the meeting, votes must be submitted TODAY in order to be received in time to be counted for tomorrow’s formal deadline.

IF YOU ALREADY VOTED “FOR” ALL PROPOSALS AND SUBMITTED YOUR PROXY CARD, THERE IS NOTHING ELSE YOU NEED TO DO TO SUPPORT SARISSA’S NOMINEES. YOU DO NOT NEED TO VOTE AGAIN.

Shareholders have seen tremendous value destruction at the hands of current Amarin leadership with its operational blunders and poor capital allocation decisions. The board, led by Chairman Per Wold-Olsen, takes no accountability and pays only lip service to its shareholders. Instead, in its attempt to further entrench itself, Amarin’s board has wasted significant amounts of precious shareholders capital to keep shareholder representatives off the board.

Sarissa is Amarin’s largest shareholder. Unlike the current board, we have meaningful “skin in the game” and are fully aligned with shareholders and incentivized to create value at Amarin. In addition, our slate includes Sarissa candidates that helped turn around The Medicines Company until its ultimate sale for nearly $10 billion. We have the qualifications and the experience to help guide Amarin through this critical period.

We urge all shareholders to vote “FOR” the Sarissa Nominees and “FOR” the removal of Chairman Per Wold-Olsen by midnight (New York Time) tonight.

You can vote on the blue proxy card or the white proxy card but if you want to fully support Sarissa, you must make sure that all “FOR” boxes are marked on your proxy card (blue or white) before you submit it.

If you have any questions on how to vote, we recommend that you contact Sarissa’s proxy solicitor, D.F. King, by calling (800) 331-7024 or emailing AMRN@dfking.com.

Visit our website at www.freeamarin.com for helpful information about Sarissa and the need for change at Amarin.

The General Meeting of Amarin shareholders is scheduled for February 28, 2023, BUT TO MAKE SURE YOUR VOTE COUNTS, SUBMIT YOUR VOTE BY MIDNIGHT (NEW YORK TIME) TONIGHT.

Additional Information

Sarissa Capital Management LP (“Sarissa Capital”), together with other participants, filed a definitive proxy statement and an accompanying blue proxy card with the SEC on January 31, 2023, in connection with the solicitation of shareholders of Amarin Corporation plc (the “Company”) at the general meeting of the Company for the election of Sarissa Capital’s slate of highly-qualified nominees (the “General Meeting”). Shareholders are advised to read the definitive proxy statement and other relevant documents related to the General Meeting as they contain important information.

The definitive proxy statement and other relevant documents are available at no charge on the SEC’s website at www.sec.gov and at www.freeamarin.com. The definitive proxy statement and other relevant documents are also available at no charge by directing a request to Sarissa Capital’s proxy solicitor, D.F. King & Co., Inc., 48 Wall Street, New York, New York 10005 (Shareholders can call toll-free: (800) 331-7024).

#FreeAmarin

View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005423/en/

Jean Puong

Sarissa Capital Management LP

info@sarissacap.com

Source: Sarissa Capital Management LP

FAQ

What is the current vote situation for Amarin Corporation (AMRN)?

Sarissa Capital is urging shareholders to vote 'FOR' board changes by midnight (New York Time) today.

Who is urging changes at Amarin Corporation?

Sarissa Capital Management LP is advocating for changes in the Amarin board.

What date is the general meeting for Amarin shareholders?

The general meeting for Amarin shareholders is scheduled for February 28, 2023.

Why does Sarissa Capital want to remove Chairman Per Wold-Olsen?

Sarissa claims that Per Wold-Olsen's leadership has led to significant value destruction and operational failures.

What experience do Sarissa's nominees bring to Amarin Corporation?

Sarissa's nominees have experience in turnaround situations, notably with The Medicines Company.